Vor Biopharma (VOR) Competitors

Vor Biopharma (NASDAQ:VOR) and Phibro Animal Health (NASDAQ:PAHC) are both small-cap pharmaceutical products companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, profitability, institutional ownership, media sentiment, earnings, dividends and analyst recommendations.

Which has more volatility & risk, VOR or PAHC?

Vor Biopharma has a beta of 2.04, suggesting that its stock price is 104% more volatile than the S&P 500. Comparatively, Phibro Animal Health has a beta of 0.75, suggesting that its stock price is 25% less volatile than the S&P 500.

Which has higher earnings and valuation, VOR or PAHC?

Phibro Animal Health has higher revenue and earnings than Vor Biopharma. Vor Biopharma is trading at a lower price-to-earnings ratio than Phibro Animal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vor Biopharma	N/A	N/A	N/A	-$1.51	-1.46
Phibro Animal Health	$1.02B	1.17	$2.42M	$0.78	37.71

Do analysts recommend VOR or PAHC?

Phibro Animal Health has a consensus price target of $24.40, indicating a potential downside of 17.04%. Given Phibro Animal Health's higher probable upside, analysts clearly believe Phibro Animal Health is more favorable than Vor Biopharma.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vor Biopharma	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	4.00
Phibro Animal Health	2 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.83

Does the media refer more to VOR or PAHC?

In the previous week, Phibro Animal Health had 2 more articles in the media than Vor Biopharma. MarketBeat recorded 4 mentions for Phibro Animal Health and 2 mentions for Vor Biopharma. Phibro Animal Health's average media sentiment score of 0.99 beat Vor Biopharma's score of 0.00 indicating that Phibro Animal Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Vor Biopharma	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Phibro Animal Health	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do institutionals and insiders believe in VOR or PAHC?

97.3% of Vor Biopharma shares are owned by institutional investors. Comparatively, 99.3% of Phibro Animal Health shares are owned by institutional investors. 2.9% of Vor Biopharma shares are owned by company insiders. Comparatively, 50.1% of Phibro Animal Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Is VOR or PAHC more profitable?

Phibro Animal Health has a net margin of 2.68% compared to Vor Biopharma's net margin of 0.00%. Phibro Animal Health's return on equity of 30.51% beat Vor Biopharma's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Vor Biopharma	N/A	N/A	N/A
Phibro Animal Health	2.68%	30.51%	6.89%

Summary

Phibro Animal Health beats Vor Biopharma on 11 of the 14 factors compared between the two stocks.